TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/14/25 08:59 | 10/9/25 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | MA | D | P | 2,250 | 19.19 | 0 | 117 | 5 | 2,619 | M | |||||||||||||||
6/25/25 20:07 | 6/23/25 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | CA | D | P.m | 5,277 | 21.11 | 0 | 250 | 7 | 3,597 | I | |||||||||||||||
9/27/24 16:26 | 9/27/24 | BIOA | Bioage Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | CA | D | P.d | 7,200 | 18.00 | 0 | 400 | 31 | 1,711 | I | |||||||||||||||
9/16/24 20:57 | 9/16/24 | ZBIO | Zenas Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | MA | D | P.d | 7,480 | 17.00 | 0 | 440 | 132 | 775 | I | |||||||||||||||
8/15/23 17:45 | 8/14/23 | JAZZ | Jazz Pharmaceuticals Plc | L2 | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | L2 | D | S | -171 | 138.16 | 0 | -1 | -6 | 21 | D | |||||||||||||||
2/8/23 19:32 | 2/6/23 | VERA | Vera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | CA | DT | P | 12,000 | 7.00 | 0 | 1,714 | 50 | 5,144 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |